Replies to post #7894 on Halozyme Therapeutics Inc (HALO)

[biotechinvestor1]

Merck has about 8.7 billion in cash on its balance sheet. That would be about a 70% premium to halo’s market cap. I think the halo’s board might consider it. LOL

[OncoJock]

Or ... West Pharmaceutical Services in Exton, PA (NYSE: WST) should buy HALO.